FDA Approved: DASATINIB — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s generic dasatinib (DASATINIB) under an Original Application (ANDA) for use in Philadelphia chromosome–positive leukemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)